Extracorporeal Membrane Oxygenation Complication
1
Pipeline Programs
5
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
UNION therapeuticsDenmark - Hellerup
1 programextracorporeal membrane oxygenationN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Utah MedicalPlatelet Transfusion
GrifolsAntithrombin III
UNION therapeuticsextracorporeal membrane oxygenation
Clinical Trials (3)
Total enrollment: 377 patients across 3 trials
ECMO Hemostatic Transfusions in Children
Start: Dec 2023Est. completion: Mar 202550 patients
Phase 4Completed
Evaluation Of The Pharmacokinetics Of Antithrombin III In Neonates And Infants Undergoing CPB And ECMO Support
Start: Jun 2015Est. completion: Jun 201827 patients
Phase 1Completed
Registry Study of Extracorporeal Cardiopulmonary Resuscitation (eCPR) in China
Start: Sep 2021Est. completion: Dec 2023300 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
5 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.